再次手術中央區淋巴結清掃中甲狀旁腺保護的難點及策略_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 程若川 , 劉文

昆明醫科大學第一附屬醫院甲狀腺疾病診治中心（昆明 650031）;

Corresponding?author：

程若川, Email: cruochuan@foxmail.com

Keywords：

DOI：

10.7507/1007-9424.201707100

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 程若川, 劉文. 再次手術中央區淋巴結清掃中甲狀旁腺保護的難點及策略. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2017, 24(10): 1173-1179. doi: 10.7507/1007-9424.201707100 Copy

1.	Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level. Chin J Cancer Res, 2017, 29(1): 1-10.
2.	Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
3.	中華醫學會內分泌學分會, 中華醫學會外科學分會內分泌學組, 中國抗癌協會頭頸腫瘤專業委員會, 等. 甲狀腺結節和分化型甲狀腺癌診治指南. 中華內分泌代謝雜志, 2012, 28(10): 779-797.0.
4.	Mitchell AL, Gandhi A, Scott-Coombes D, et al. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol, 2016, 130(S2): S150-S160.
5.	鄭魯明, 賀青卿, 莊大勇, 等. 分化型甲狀腺癌再次手術 57 例臨床分析. 中國現代普通外科進展, 2014, 17(8): 598-601.0.
6.	李向陽, 丁友宏, 邱亮, 等. 分化型甲狀腺癌再次手術 97 例臨床分析. 山東醫藥, 2013, 53(30): 62-63.0.
7.	鄭緒才, 王圣應, 朱正志, 等. 分化型甲狀腺癌再次手術的臨床分析. 安徽醫學, 2015, 36(9): 1074-1076.0.
8.	陳衛賢, 蔣斌, 顧云飛, 等. 分化型甲狀腺癌再次手術的原因和策略. 中國眼耳鼻喉科雜志, 2014, 14(1): 42-43.0.
9.	王莎飛. 甲狀腺癌不規范手術后再手術相關問題的探討. 基層醫學論壇, 2015, 19(31): 4349-4350.0.
10.	許德斌, 呂云霞, 陳萬志, 等. 甲狀腺癌再次手術的原因及手術方案分析. 江西醫藥, 2016, 51(6): 524-526.0.
11.	李潔清, 魏濤, 朱啟波, 等. 甲狀腺乳頭狀癌再次手術的原因探討. 中國普外基礎與臨床雜志, 2012, 19(8): 818-822.0.
12.	Manouras A, Markogiannakis H, Lagoudianakis E, et al. Unintentional parathyroidectomy during total thyroidectomy. Head Neck, 2008, 30(4): 497-502.
13.	Gourgiotis S, Moustafellos P, Dimopoulos N, et al. Inadvertent parathyroidectomy during thyroid surgery: the incidence of a complication of thyroidectomy. Langenbecks Arch Surg, 2006, 391(6): 557-560.
14.	Paek SH, Lee YM, Min SY, et al. Risk factors of hypoparathyroidism following total thyroidectomy for thyroid cancer. World J Surg, 2013, 37(1): 94-101.
15.	Ondik MP, McGinn J, Ruggiero F, et al. Unintentional parathyroidectomy and hypoparathyroidism in secondary central compartment surgery for thyroid cancer. Head Neck, 2010, 32(4): 462-466.
16.	Sitges-Serra A, Gallego-Otaegui L, Suárez S, et al. Inadvertent parathyroidectomy during total thyroidectomy and central neck dissection for papillary thyroid carcinoma. Surgery, 2017, 161(3) :712-719.
17.	Zhou HY, He JC, McHenry CR. Inadvertent parathyroidectomy: incidence, risk factors, and outcomes. J Surg Res, 2016, 205(1): 70-75.
18.	Mehanna H, Al-Maqbili T, Carter B, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab, 2014, 99(8): 2834-2843.
19.	Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid, 2012, 22(11): 1144-1152.
20.	Lang BH, Wong CK, Tsang JS, et al. A systematic review and meta-analysis comparing surgically-related complications between robotic-assisted thyroidectomy and conventional open thyroidectomy. Ann Surg Oncol, 2014, 21(3): 850-861.
21.	Wang TS, Cheung K, Farrokhyar F, et al. A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. Ann Surg Oncol, 2013, 20(11): 3477-3483.
22.	Radowsky JS, Howard RS, Burch HB, et al. Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome. Thyroid, 2014, 24(2): 241-244.
23.	Woo CG, Sung CO, Choi YM, et al. Clinicopathological significance of minimal extrathyroid extension in solitary papillary thyroid carcinomas. Ann Surg Oncol, 2015, 22 Suppl 3: S728-S733.
24.	Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin, 2017, 67(2): 93-99.
25.	中國抗癌協會甲狀腺癌專業委員會 (CATO). 甲狀腺微小乳頭狀癌診斷與治療中國專家共識 (2016 版). 中國腫瘤臨床, 2016, 43(10): 405-411.0.
26.	劉文, 程若川, 蘇艷軍, 等. 2015 版美國甲狀腺協會指南 cN0 甲狀腺乳頭狀癌手術方案合理性分析. 中國實用外科雜志, 2017, 37(5): 568-571.0.
27.	中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺手術中甲狀旁腺保護專家共識. 中國實用外科雜志, 2015, 35(7): 731-736.0.
28.	程若川, 艾楊卿, 刁暢, 等. 甲狀腺手術中甲狀旁腺顯露及功能保護的臨床研究. 中國普外基礎與臨床雜志, 2009, 16(5): 351-355.0.
29.	Zhu J, Tian W, Xu Z, et al. Expert consensus statement on parathyroid protection in thyroidectomy. Ann Transl Med, 2015, 3(16): 230.
30.	Randolph GW 著; 田文, 姜可偉譯. 甲狀腺和甲狀旁腺外科學. 第 2 版. 北京: 北京大學醫學出版社, 2016: 17-26.
31.	Tuttle RM, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid, 2010, 20(12): 1341-1349.
32.	Vaisman F, Tala H, Grewal R, et al. In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid, 2011, 21(12): 1317-1322.
33.	Al-Saif O, Farrar WB, Bloomston M, et al. Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab, 2010, 95(5): 2187-2194.
34.	Schuff KG, Weber SM, Givi B, et al. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope, 2008, 118(5): 768-775.
35.	Yim JH, Kim WB, Kim EY, et al. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab, 2011, 96(7): 2049-2056.
36.	Leenhardt L, Erdogan MF, Hegedus L, et al. 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J, 2013, 2(3): 147-159.
37.	Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab, 2007, 92(9): 3590-3594.
38.	Kuna SK, Bracic I, Tesic V, et al. Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med, 2006, 25(12): 1531-1537.
39.	Rondeau G, Fish S, Hann LE, et al. Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid, 2011, 21(8): 845-853.
40.	Robenshtok E, Fish S, Bach A, et al. Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab, 2012, 97(8): 2706-2713.
41.	Ito Y, Higashiyama T, Takamura Y, et al. Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck. World J Surg, 2011, 35(4): 767-772.
42.	Uchida H, Imai T, Kikumori T, et al. Long-term results of surgery for papillary thyroid carcinoma with local recurrence. Surg Today, 2013, 43(8): 848-853.
43.	中國臨床腫瘤學會甲狀腺癌專業委員會. 復發轉移性分化型甲狀腺癌診治共識. 中國癌癥雜志, 2015, 25(7): 481-496.0.
44.	韓永紅, 明小燕, 張家銘. Zuckerkandl 結節在甲狀腺手術中對上甲狀旁腺的定位與保護. 醫學與哲學, 2014, 35(2B): 30-31, 64.0.
45.	Gurleyik E, Gurleyik G. Incidence and surgical importance of Zuckerkandl’s tubercle of the thyroid and its relations with recurrent laryngeal nerve. ISRN Surg, 2012, 2012: 450589.
46.	Falco J, Dip F, Quadri P, et al. Increased identification of parathyroid glands using near infrared light during thyroid and parathyroid surgery. Surg Endosc, 2017, [Epub ahead of print].
47.	Hou F, Yu Y, Liang Y. Automatic identification of parathyroid in optical coherence tomography images. Lasers Surg Med, 2017, 49(3): 305-311.
48.	McWade MA, Sanders ME, Broome JT, et al. Establishing the clinical utility of autofluorescence spectroscopy for parathyroid detection. Surgery, 2016, 159(1): 193-202.
49.	Shinden Y, Nakajo A, Arima H, et al. Intraoperative identification of the parathyroid gland with a fluorescence detection system. World J Surg, 2017, 41(6): 1506-1512.
50.	鐘琦, 房居高, 馬泓智, 等. 經靜脈低劑量亞甲藍甲狀旁腺定位在甲狀腺手術中的初步應用. 中國耳鼻咽喉頭頸外科, 2016, 23(5): 247-249.0.
51.	李永平, 楊莉, 李南林, 等. 術中穿刺檢測鑒別淋巴結與甲狀旁腺 28 例臨床研究. 中國實用外科雜志, 2016, 36(11): 1224-1232.0.
52.	馬云海, 程若川. 甲狀腺癌的超聲管理——外科醫生的基本功. 中國普通外科雜志, 2017, 26(5): 551-555.0.
53.	Duclos A, Peix JL, Colin C, et al. Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study. BMJ, 2012, 344: d8041.
54.	張亞冰, 張彬, 鄢丹桂, 等. 甲狀腺癌中央區域再次手術并發癥的臨床分析. 中華耳鼻咽喉頭頸外科雜志, 2017, 52(4): 263-266.0.
55.	廖泉. 甲狀腺外科手術中甲狀旁腺功能保護. 中國實用外科雜志, 2015, 35(6): 672-673.0.
56.	Foreman E, Aspinall S, Bliss RD, et al. The use of the harmonic scalpel in thyroidectomy: ‘beyond the learning curve’. Ann R Coll Surg Engl, 2009, 91(3): 214-216.
57.	鄒巖. 顯微鏡下雙極電凝輔助甲狀旁腺原位保留的臨床研究. 中國現代醫生, 2017, 55(10): 42-44.0.
58.	Testini M, Rosato L, Avenia N, et al. The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study. Transplant Proc, 2007, 39(1): 225-230.
59.	Bergenfelz A, Jansson S, Kristoffersson A, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg, 2008, 393(5): 667-673.
60.	Ito Y, Kihara M, Kobayashi K, et al. Permanent hypoparathyroidism after completion total thyroidectomy as a second surgery: how do we avoid it? Endocr J, 2014, 61(4): 403-408.
61.	Wei T, Li Z, Jin J, et al. Autotransplantation of inferior parathyroid glands during central neck dissection for papillary thyroid carcinoma: a retrospective cohort study. Int J Surg, 2014, 12(12): 1286-1290.
62.	張浩. Ⅵ區淋巴結清掃術中甲狀旁腺保護和損傷處理. 中國實用外科雜志, 2012, 32(5): 361-363.0.
63.	馬云海, 錢軍, 李書聆, 等. 內鏡觀察術中原位保留甲狀旁腺可行性研究. 中國實用外科雜志, 2016, 36(5): 543-546.0.
64.	蘇艷軍, 劉彬, 刁暢, 等. 甲狀腺術中甲狀旁腺體外保存后自體移植對其功能影響的研究. 重慶醫學, 2017, 46(8): 1032-1035.0.
65.	Ali S, Yu C, Palmer FL, et al. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia. Arch Otolaryngol Head Neck Surg, 2011, 137(11): 1154-1160.
66.	Lang BH, Yih PC, Ng KK. A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy. World J Surg, 2012, 36(6): 1300-1306.
67.	Amir A, Sands NB, Tamilia M, et al. Preoperative serum calcium levels as an indicator of postthyroidectomy hypocalcemia. J Otolaryngol Head Neck Surg, 2010, 39(6): 654-658.
68.	Erbil Y, Ozbey NC, Sari S, et al. Determinants of postoperative hypocalcemia in vitamin D-deficient Graves’ patients after total thyroidectomy. Am J Surg, 2011, 201(5): 685-691.
69.	Kirkby-Bott J, Markogiannakis H, Skandarajah A, et al. Preoperative vitamin D deficiency predicts postoperative hypocalcemia after total thyroidectomy. World J Surg, 2011, 35(2): 324-330.
70.	Erbil Y, Barbaros U, Temel B, et al. The impact of age, vitamin D(3) level, and incidental parathyroidectomy on postoperative hypocalcemia after total or near total thyroidectomy. Am J Surg, 2009, 197(4): 439-446.
71.	Edafe O, Antakia R, Laskar N, et al. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg, 2014, 101(4): 307-320.
72.	劉文, 閆雪晶, 程若川, 等. 甲狀腺術后低鈣血癥早期預測研究進展. 中國實用外科雜志, 2016, 36(11): 1234-1237.0.
73.	程若川, 陳會彬, 刁暢, 等. 甲狀腺全切術后預防性補鈣對甲狀旁腺功能的影響. 中華內分泌外科雜志, 2012, 6(4): 243-246.0.
74.	Morris R, Yen TWF, Doffek K, et al. Concurrent endocrine and other surgical procedures: an institutional experience. J Surg Res, 2017, 211: 107-113.
75.	Ayala MA, Yencha MW. Outpatient thyroid surgery in a low-surgical volume hospital. World J Surg, 2015, 39(9): 2253-2258.

1. Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level. Chin J Cancer Res, 2017, 29(1): 1-10.
2. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
3. 中華醫學會內分泌學分會, 中華醫學會外科學分會內分泌學組, 中國抗癌協會頭頸腫瘤專業委員會, 等. 甲狀腺結節和分化型甲狀腺癌診治指南. 中華內分泌代謝雜志, 2012, 28(10): 779-797.0.
4. Mitchell AL, Gandhi A, Scott-Coombes D, et al. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol, 2016, 130(S2): S150-S160.
5. 鄭魯明, 賀青卿, 莊大勇, 等. 分化型甲狀腺癌再次手術 57 例臨床分析. 中國現代普通外科進展, 2014, 17(8): 598-601.0.
6. 李向陽, 丁友宏, 邱亮, 等. 分化型甲狀腺癌再次手術 97 例臨床分析. 山東醫藥, 2013, 53(30): 62-63.0.
7. 鄭緒才, 王圣應, 朱正志, 等. 分化型甲狀腺癌再次手術的臨床分析. 安徽醫學, 2015, 36(9): 1074-1076.0.
8. 陳衛賢, 蔣斌, 顧云飛, 等. 分化型甲狀腺癌再次手術的原因和策略. 中國眼耳鼻喉科雜志, 2014, 14(1): 42-43.0.
9. 王莎飛. 甲狀腺癌不規范手術后再手術相關問題的探討. 基層醫學論壇, 2015, 19(31): 4349-4350.0.
10. 許德斌, 呂云霞, 陳萬志, 等. 甲狀腺癌再次手術的原因及手術方案分析. 江西醫藥, 2016, 51(6): 524-526.0.
11. 李潔清, 魏濤, 朱啟波, 等. 甲狀腺乳頭狀癌再次手術的原因探討. 中國普外基礎與臨床雜志, 2012, 19(8): 818-822.0.
12. Manouras A, Markogiannakis H, Lagoudianakis E, et al. Unintentional parathyroidectomy during total thyroidectomy. Head Neck, 2008, 30(4): 497-502.
13. Gourgiotis S, Moustafellos P, Dimopoulos N, et al. Inadvertent parathyroidectomy during thyroid surgery: the incidence of a complication of thyroidectomy. Langenbecks Arch Surg, 2006, 391(6): 557-560.
14. Paek SH, Lee YM, Min SY, et al. Risk factors of hypoparathyroidism following total thyroidectomy for thyroid cancer. World J Surg, 2013, 37(1): 94-101.
15. Ondik MP, McGinn J, Ruggiero F, et al. Unintentional parathyroidectomy and hypoparathyroidism in secondary central compartment surgery for thyroid cancer. Head Neck, 2010, 32(4): 462-466.
16. Sitges-Serra A, Gallego-Otaegui L, Suárez S, et al. Inadvertent parathyroidectomy during total thyroidectomy and central neck dissection for papillary thyroid carcinoma. Surgery, 2017, 161(3) :712-719.
17. Zhou HY, He JC, McHenry CR. Inadvertent parathyroidectomy: incidence, risk factors, and outcomes. J Surg Res, 2016, 205(1): 70-75.
18. Mehanna H, Al-Maqbili T, Carter B, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab, 2014, 99(8): 2834-2843.
19. Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid, 2012, 22(11): 1144-1152.
20. Lang BH, Wong CK, Tsang JS, et al. A systematic review and meta-analysis comparing surgically-related complications between robotic-assisted thyroidectomy and conventional open thyroidectomy. Ann Surg Oncol, 2014, 21(3): 850-861.
21. Wang TS, Cheung K, Farrokhyar F, et al. A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. Ann Surg Oncol, 2013, 20(11): 3477-3483.
22. Radowsky JS, Howard RS, Burch HB, et al. Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome. Thyroid, 2014, 24(2): 241-244.
23. Woo CG, Sung CO, Choi YM, et al. Clinicopathological significance of minimal extrathyroid extension in solitary papillary thyroid carcinomas. Ann Surg Oncol, 2015, 22 Suppl 3: S728-S733.
24. Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin, 2017, 67(2): 93-99.
25. 中國抗癌協會甲狀腺癌專業委員會 (CATO). 甲狀腺微小乳頭狀癌診斷與治療中國專家共識 (2016 版). 中國腫瘤臨床, 2016, 43(10): 405-411.0.
26. 劉文, 程若川, 蘇艷軍, 等. 2015 版美國甲狀腺協會指南 cN0 甲狀腺乳頭狀癌手術方案合理性分析. 中國實用外科雜志, 2017, 37(5): 568-571.0.
27. 中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺手術中甲狀旁腺保護專家共識. 中國實用外科雜志, 2015, 35(7): 731-736.0.
28. 程若川, 艾楊卿, 刁暢, 等. 甲狀腺手術中甲狀旁腺顯露及功能保護的臨床研究. 中國普外基礎與臨床雜志, 2009, 16(5): 351-355.0.
29. Zhu J, Tian W, Xu Z, et al. Expert consensus statement on parathyroid protection in thyroidectomy. Ann Transl Med, 2015, 3(16): 230.
30. Randolph GW 著; 田文, 姜可偉譯. 甲狀腺和甲狀旁腺外科學. 第 2 版. 北京: 北京大學醫學出版社, 2016: 17-26.
31. Tuttle RM, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid, 2010, 20(12): 1341-1349.
32. Vaisman F, Tala H, Grewal R, et al. In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid, 2011, 21(12): 1317-1322.
33. Al-Saif O, Farrar WB, Bloomston M, et al. Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab, 2010, 95(5): 2187-2194.
34. Schuff KG, Weber SM, Givi B, et al. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope, 2008, 118(5): 768-775.
35. Yim JH, Kim WB, Kim EY, et al. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab, 2011, 96(7): 2049-2056.
36. Leenhardt L, Erdogan MF, Hegedus L, et al. 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J, 2013, 2(3): 147-159.
37. Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab, 2007, 92(9): 3590-3594.
38. Kuna SK, Bracic I, Tesic V, et al. Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med, 2006, 25(12): 1531-1537.
39. Rondeau G, Fish S, Hann LE, et al. Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid, 2011, 21(8): 845-853.
40. Robenshtok E, Fish S, Bach A, et al. Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab, 2012, 97(8): 2706-2713.
41. Ito Y, Higashiyama T, Takamura Y, et al. Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck. World J Surg, 2011, 35(4): 767-772.
42. Uchida H, Imai T, Kikumori T, et al. Long-term results of surgery for papillary thyroid carcinoma with local recurrence. Surg Today, 2013, 43(8): 848-853.
43. 中國臨床腫瘤學會甲狀腺癌專業委員會. 復發轉移性分化型甲狀腺癌診治共識. 中國癌癥雜志, 2015, 25(7): 481-496.0.
44. 韓永紅, 明小燕, 張家銘. Zuckerkandl 結節在甲狀腺手術中對上甲狀旁腺的定位與保護. 醫學與哲學, 2014, 35(2B): 30-31, 64.0.
45. Gurleyik E, Gurleyik G. Incidence and surgical importance of Zuckerkandl’s tubercle of the thyroid and its relations with recurrent laryngeal nerve. ISRN Surg, 2012, 2012: 450589.
46. Falco J, Dip F, Quadri P, et al. Increased identification of parathyroid glands using near infrared light during thyroid and parathyroid surgery. Surg Endosc, 2017, [Epub ahead of print].
47. Hou F, Yu Y, Liang Y. Automatic identification of parathyroid in optical coherence tomography images. Lasers Surg Med, 2017, 49(3): 305-311.
48. McWade MA, Sanders ME, Broome JT, et al. Establishing the clinical utility of autofluorescence spectroscopy for parathyroid detection. Surgery, 2016, 159(1): 193-202.
49. Shinden Y, Nakajo A, Arima H, et al. Intraoperative identification of the parathyroid gland with a fluorescence detection system. World J Surg, 2017, 41(6): 1506-1512.
50. 鐘琦, 房居高, 馬泓智, 等. 經靜脈低劑量亞甲藍甲狀旁腺定位在甲狀腺手術中的初步應用. 中國耳鼻咽喉頭頸外科, 2016, 23(5): 247-249.0.
51. 李永平, 楊莉, 李南林, 等. 術中穿刺檢測鑒別淋巴結與甲狀旁腺 28 例臨床研究. 中國實用外科雜志, 2016, 36(11): 1224-1232.0.
52. 馬云海, 程若川. 甲狀腺癌的超聲管理——外科醫生的基本功. 中國普通外科雜志, 2017, 26(5): 551-555.0.
53. Duclos A, Peix JL, Colin C, et al. Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study. BMJ, 2012, 344: d8041.
54. 張亞冰, 張彬, 鄢丹桂, 等. 甲狀腺癌中央區域再次手術并發癥的臨床分析. 中華耳鼻咽喉頭頸外科雜志, 2017, 52(4): 263-266.0.
55. 廖泉. 甲狀腺外科手術中甲狀旁腺功能保護. 中國實用外科雜志, 2015, 35(6): 672-673.0.
56. Foreman E, Aspinall S, Bliss RD, et al. The use of the harmonic scalpel in thyroidectomy: ‘beyond the learning curve’. Ann R Coll Surg Engl, 2009, 91(3): 214-216.
57. 鄒巖. 顯微鏡下雙極電凝輔助甲狀旁腺原位保留的臨床研究. 中國現代醫生, 2017, 55(10): 42-44.0.
58. Testini M, Rosato L, Avenia N, et al. The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study. Transplant Proc, 2007, 39(1): 225-230.
59. Bergenfelz A, Jansson S, Kristoffersson A, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg, 2008, 393(5): 667-673.
60. Ito Y, Kihara M, Kobayashi K, et al. Permanent hypoparathyroidism after completion total thyroidectomy as a second surgery: how do we avoid it? Endocr J, 2014, 61(4): 403-408.
61. Wei T, Li Z, Jin J, et al. Autotransplantation of inferior parathyroid glands during central neck dissection for papillary thyroid carcinoma: a retrospective cohort study. Int J Surg, 2014, 12(12): 1286-1290.
62. 張浩. Ⅵ區淋巴結清掃術中甲狀旁腺保護和損傷處理. 中國實用外科雜志, 2012, 32(5): 361-363.0.
63. 馬云海, 錢軍, 李書聆, 等. 內鏡觀察術中原位保留甲狀旁腺可行性研究. 中國實用外科雜志, 2016, 36(5): 543-546.0.
64. 蘇艷軍, 劉彬, 刁暢, 等. 甲狀腺術中甲狀旁腺體外保存后自體移植對其功能影響的研究. 重慶醫學, 2017, 46(8): 1032-1035.0.
65. Ali S, Yu C, Palmer FL, et al. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia. Arch Otolaryngol Head Neck Surg, 2011, 137(11): 1154-1160.
66. Lang BH, Yih PC, Ng KK. A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy. World J Surg, 2012, 36(6): 1300-1306.
67. Amir A, Sands NB, Tamilia M, et al. Preoperative serum calcium levels as an indicator of postthyroidectomy hypocalcemia. J Otolaryngol Head Neck Surg, 2010, 39(6): 654-658.
68. Erbil Y, Ozbey NC, Sari S, et al. Determinants of postoperative hypocalcemia in vitamin D-deficient Graves’ patients after total thyroidectomy. Am J Surg, 2011, 201(5): 685-691.
69. Kirkby-Bott J, Markogiannakis H, Skandarajah A, et al. Preoperative vitamin D deficiency predicts postoperative hypocalcemia after total thyroidectomy. World J Surg, 2011, 35(2): 324-330.
70. Erbil Y, Barbaros U, Temel B, et al. The impact of age, vitamin D(3) level, and incidental parathyroidectomy on postoperative hypocalcemia after total or near total thyroidectomy. Am J Surg, 2009, 197(4): 439-446.
71. Edafe O, Antakia R, Laskar N, et al. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg, 2014, 101(4): 307-320.
72. 劉文, 閆雪晶, 程若川, 等. 甲狀腺術后低鈣血癥早期預測研究進展. 中國實用外科雜志, 2016, 36(11): 1234-1237.0.
73. 程若川, 陳會彬, 刁暢, 等. 甲狀腺全切術后預防性補鈣對甲狀旁腺功能的影響. 中華內分泌外科雜志, 2012, 6(4): 243-246.0.
74. Morris R, Yen TWF, Doffek K, et al. Concurrent endocrine and other surgical procedures: an institutional experience. J Surg Res, 2017, 211: 107-113.
75. Ayala MA, Yencha MW. Outpatient thyroid surgery in a low-surgical volume hospital. World J Surg, 2015, 39(9): 2253-2258.

Previous Article
甲狀旁腺功能與甲狀腺外科的診治進展
Next Article
達芬奇機器人甲狀腺手術中甲狀旁腺保護策略與技巧

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

再次手術中央區淋巴結清掃中甲狀旁腺保護的難點及策略

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content